Endoscopic management for patients with serrated polyposis syndrome is feasible and effective : A prospective observational study at a tertiary center.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005031

Enrollment

Registered

2013-05-28

Start date

2010-09-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18

Interventions

Group 1: Data acquisation of all included patients regarding age, gender, number and morphology of polyps, rate of carcinoma, number and time of endoscopic interventions needed for complete resection

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients who fullfilled the criteria (WHO) for serrated polyposis syndrom

Exclusion criteria

Exclusion criteria: Patients who had severe comorbidity (over grade III in the American Society of Anesthesiologists classification) or were receiving oral anticoagulation treatment were excluded

Design outcomes

Primary

Measure	Time frame
Rate of complete Remission after 3-6 months and rate of residual lesions, recurrences and intervall carcinomas during surveillance. The surveillance interval is at least 12 months.	—

Secondary

Measure	Time frame
complications, rate of colorectal carcinomas at first resection and during surveillance ( At least one year) Evaluation of cancer rate in first degree relatives (questionnaire)	—

Countries

Germany

Contacts

Public ContactJürgen Pohl

Dr. Horst-Schmidt Klinik

Juergen.Pohl@hsk-wiesbaden.de0611432420

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026